Breakthrough COPD Treatment Awaits FDA Approval Promising Major Market Impact
Verona Pharma is poised for a pivotal breakthrough with its drug candidate, ensifentrine, potentially transforming COPD treatment pending an … Share on FacebookTweetFollow usSave
